Who Paid My Doc
Nadia Waheed
Uveitis and Ocular Inflammatory Disease Boston, MA Medical Doctor
NPI 1245214915 CMS profile 56119
800 Washington St, Boston, MA 02111
General payments
$346,225
Research payments
$12,130
Ownership & investment interest
$0
Research they led as principal investigator
$755,287
Through program year 2025, Nadia Waheed of Boston, MA is reported in the CMS Open Payments database as having received $346,225 across 148 general payments and $12,130 in research payments paid to them. Separately, studies naming them as principal investigator received $755,287 in research payments, paid to institutions rather than to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.
By program year
9 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $56,000 | 6 | |
| 2024 | General | $49,808 | 17 | |
| 2023 | General | $48,635 | 33 | |
| 2022 | General | $17,074 | 3 | |
| 2021 | General | $37,923 | 5 | |
| 2020 | General | $17,018 | 11 | |
| 2020 | Research | $1,513 | 2 | |
| 2019 | General | $119,767 | 73 | |
| 2019 | Research | $10,617 | 2 |
Beside peers
- Nadia Waheed
- Uveitis and Ocular Inflammatory Disease median
- Middle half of Uveitis and Ocular Inflammatory Disease
- National median
In program year 2025, general payments to Nadia Waheed were reported at $56,000. Among 42 Uveitis and Ocular Inflammatory Disease profiles paid that year, the median was $471 and the middle half received between $198 and $5,376.
Show as a table
| Year | Nadia Waheed | Uveitis and Ocular Inflammatory Disease median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $119,767 | $403 | $156–$5,734 | $163 |
| 2020 | $17,018 | $164 | $99–$6,393 | $114 |
| 2021 | $37,923 | $240 | $102–$2,572 | $132 |
| 2022 | $17,074 | $503 | $154–$5,143 | $149 |
| 2023 | $48,635 | $655 | $222–$5,436 | $160 |
| 2024 | $49,808 | $567 | $227–$2,571 | $164 |
| 2025 | $56,000 | $471 | $198–$5,376 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Billing to Medicare
Part B · data year 2024 · 11 billing codesPaid by Medicare
$20,940
Medicare patients
175
Services billed
426
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| High blood pressure | 75% | |
| Diabetes | 49% | |
| Arthritis | 44% | |
| Chronic kidney disease | 33% | |
| Ischemic heart disease | 27% | |
| Depression | 21% | |
| Osteoporosis | 19% | |
| Cancer | 18% |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
152 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Uveitis and Ocular Inflammatory Disease in Massachusetts
Caroline Baumal
Uveitis and Ocular Inflammatory Disease · Boston, MA
Elias Reichel
Uveitis and Ocular Inflammatory Disease · Boston, MA
Lana Rifkin
Uveitis and Ocular Inflammatory Disease · Boston, MA
Jay Duker
Uveitis and Ocular Inflammatory Disease · Boston, MA
Andrew Tye
Uveitis and Ocular Inflammatory Disease · Boston, MA
Sarkis Soukiasian
Uveitis and Ocular Inflammatory Disease · Burlington, MA
Related records
Uveitis and Ocular Inflammatory Disease in Massachusetts
Practitioners in the same specialty and state, ranked by reported value.
All Uveitis and Ocular Inflammatory Disease
Everyone recorded under this specialty, nationwide.
Doctors in Massachusetts
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.